Tellgen Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002P42
CNY
18.60
-0.1 (-0.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of -0.37% and Operating profit at -22.12% over the last 5 years

 
2

With a fall in EPS of -76.76%, the company declared Very Negative results in Mar 25

3

With ROE of 1.63%, it has a expensive valuation with a 2.20 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 2,585 Million (Small Cap)

stock-summary
P/E

134.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.80%

stock-summary
Debt Equity

-0.13

stock-summary
Return on Equity

0.79%

stock-summary
Price to Book

1.76

Revenue and Profits:
Net Sales:
99 Million
(Quarterly Results - Sep 2025)
Net Profit:
3 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.17%
0%
-18.17%
6 Months
2.88%
0%
2.88%
1 Year
33.72%
0%
33.72%
2 Years
51.47%
0%
51.47%
3 Years
-18.35%
0%
-18.35%
4 Years
-32.95%
0%
-32.95%
5 Years
-29.07%
0%
-29.07%

Tellgen Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-0.37%
EBIT Growth (5y)
-22.12%
EBIT to Interest (avg)
76.86
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.31
Tax Ratio
15.21%
Dividend Payout Ratio
69.90%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.26%
ROE (avg)
6.84%

Valuation key factors

Factor
Value
P/E Ratio
134
Industry P/E
Price to Book Value
2.20
EV to EBIT
115.75
EV to EBITDA
31.78
EV to Capital Employed
2.66
EV to Sales
7.59
PEG Ratio
NA
Dividend Yield
0.63%
ROCE (Latest)
2.30%
ROE (Latest)
1.63%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 17.10% vs 12.42% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 92.31% vs 244.44% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "98.60",
          "val2": "84.20",
          "chgp": "17.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.10",
          "val2": "19.20",
          "chgp": "-73.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.60",
          "val2": "0.90",
          "chgp": "-166.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.50",
          "val2": "1.30",
          "chgp": "92.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "51.80%",
          "val2": "19.30%",
          "chgp": "3.25%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -19.24% vs -24.42% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -66.47% vs -31.53% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "433.50",
          "val2": "536.80",
          "chgp": "-19.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "103.90",
          "val2": "137.00",
          "chgp": "-24.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.90",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.50",
          "val2": "8.20",
          "chgp": "-130.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "28.40",
          "val2": "84.70",
          "chgp": "-66.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "72.70%",
          "val2": "96.30%",
          "chgp": "-2.36%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQstock-summary

Sep'25
Jun'25
Change(%)
Net Sales
98.60
84.20
17.10%
Operating Profit (PBDIT) excl Other Income
5.10
19.20
-73.44%
Interest
0.30
0.00
Exceptional Items
-0.60
0.90
-166.67%
Consolidate Net Profit
2.50
1.30
92.31%
Operating Profit Margin (Excl OI)
51.80%
19.30%
3.25%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 17.10% vs 12.42% in Jun 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 92.31% vs 244.44% in Jun 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
433.50
536.80
-19.24%
Operating Profit (PBDIT) excl Other Income
103.90
137.00
-24.16%
Interest
0.60
0.90
-33.33%
Exceptional Items
-2.50
8.20
-130.49%
Consolidate Net Profit
28.40
84.70
-66.47%
Operating Profit Margin (Excl OI)
72.70%
96.30%
-2.36%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -19.24% vs -24.42% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -66.47% vs -31.53% in Dec 2023

stock-summaryCompany CV
About Tellgen Corp. stock-summary
stock-summary
Tellgen Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available